Approximately half of the human brain consists of myelinated axons. Central nervous system (CNS) myelin is made by oligodendrocytes and is essential for nervous system formation, health, and function. Once thought simply as a static insulator that facilitated rapid impulse conduction, myelin is now known to be made and remodeled in to adult life. Oligodendrocytes have a remarkable capacity to differentiate by default, but many aspects of their development can be influenced by axons. However, how axons and oligodendrocytes interact and cooperate to regulate myelination in the CNS remains unclear. Here, we review recent advances in our understanding of how such interactions generate the complexity of myelination known to exist in vivo. We highlight intriguing results that indicate that the cross-sectional size of an axon alone may regulate myelination to a surprising degree. We also review new studies, which have highlighted diversity in the myelination of axons of different neuronal subtypes and circuits, and structure-function relationships, which suggest that myelinated axons can be exquisitely fine-tuned to mediate precise conduction needs. We also discuss recent advances in our understanding of how neuronal activity regulates CNS myelination, and aim to provide an integrated overview of how axon-oligodendrocyte interactions sculpt neuronal circuit structure and function.
Introduction
In our central nervous system (CNS), oligodendrocytes are the specialized glial cells that make the myelin sheaths that provide insulation and trophic support to underlying axons. Myelin also restricts the localization of the ion channels that propagate the nerve impulse to short unmyelinated gaps between consecutive sheaths, called nodes of Ranvier. Although myelination has long been known to accelerate the speed of nerve impulse propagation, in recent years it has become clear that myelin is not simply a static insulator, but a dynamic structure that regulates many aspects of nervous system health and function (reviewed in Chang and others 2016; Fields 2015; Nave and Werner 2014) . New myelin in the CNS is made well in to adult life and this occurs by the generation of new myelinating oligodendrocytes (Young and others 2013; Yeung and others 2014) , from oligodendrocyte precursor cells (OPCs) , which represent about 5% of our mature CNS (Dawson and others 2003) , and by the remodeling and renewed growth of existing myelin (Snaidero and others 2014; Yeung and others 2014; Young and others 2013) . Myelination can vary throughout the CNS, depending on the time of life, brain area, neuronal subtype, axon diameter (caliber), and the local cellular and molecular microenvironment (reviewed by Tomassy and others 2016) . Not only are individual axons either myelinated or not, but the number, distribution, length and thickness of myelin sheaths along axons are all parameters that can vary greatly between myelinated axons. Because myelin accelerates the speed of nerve impulse propagation, some axons may be myelinated simply to speed up communication between specific areas of the CNS. In addition, however, regulation of number, distribution, length, and thickness of myelin sheaths along other axons may be employed to determine precise conduction times. Because the precise timing of communication between neurons affects synaptic plasticity and the functional properties of neuronal 703030N ROXXX10.1177/1073858417703030The NeuroscientistKlingseisen and Lyons
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1 Centre for Neuroregeneration, University of Edinburgh, Edinburgh, UK ensembles, regulation of myelination has even been proposed as a form of nervous system plasticity (Baraban and others 2016; Fields 2015) . Indeed, numerous studies have implicated dynamic alterations of white matter (myelinated axons) as a key regulator of human CNS function. For example, learning how to juggle or intensive practicing of the piano, correlate with changes in white matter in specific areas of the brain, as assessed by magnetic resonance imaging (Bengtsson and others 2005; Scholz and others 2009) . Although the cellular correlates of magnetic resonance imaging-based white matter changes are only now beginning to be systematically addressed in model species (e.g., Sampaio-Baptista and others 2013), it is generally assumed that these reflect, at least in part, alterations to myelin (Fields 2015) . Work in animal models also supports a role for regulation of myelin in higher order brain function. Social isolation of mice at a specific critical period of postnatal developmental (p21-p35) (Makinodan and others 2012) or for prolonged periods (8 weeks) in adults (Liu and others 2012) can lead to myelin defects and corresponding behavioral phenotypes. Interestingly, genetic knockout of a receptor tyrosine kinase from myelinating oligodendrocytes phenocopies both the myelin defects and behavioral phenotypes caused by postnatal social isolation (Makinodan and others 2012) . Treatment with Clemastine, a drug that can promote oligodendrocyte differentiation through activating muscarinic receptor function (F. Mei and others 2014) , can rescue the defects caused by social isolation in adult mice (Liu and others 2016a) , further suggesting that major phenotypes associated with social isolation are manifest via alterations to myelin. Recent studies have also shown that motor learning promotes the differentiation of myelinating oligodendrocytes in adult mice, and conversely that impairing the ability of adult OPCs to generate new myelinating oligodendrocytes impairs learning (McKenzie and others 2014) . In addition to regulation of conduction properties and neuronal circuit function, recent evidence has revealed a role for myelin in providing metabolic support to axons (Simons and Nave 2015) . This metabolic support has been shown important for axonal health (Y. and for the maintenance of energetically expensive high-frequency neuronal activity (Saab and others 2016) . Disruption to CNS myelin is also known to contribute not only to numerous diseases of the nervous system, including demyelinating diseases such as multiple sclerosis ((Franklin and others 2012) , but also to other neurodegenerative and psychiatric conditions (e.g., Jin and others 2015; Kang and others 2013; Nave and Ehrenreich 2014), reflecting our expanding knowledge of the functions of myelinating oligodendrocytes. Despite its importance, our current understanding of how myelination in the CNS is regulated is incomplete. In this review, we will focus on our emerging knowledge of how interactions between axons and oligodendrocytes affect the formation and dynamic regulation of myelination in development and in circuit function.
Who Even Needs Axons? Oligodendrocytes Can Develop without Them!
It has been known for more than 30 years that primary oligodendrocytes can differentiate in culture in the absence of neurons or neuronal signals (e.g., Knapp and others 1987; Zeller and others 1985) . Indeed, oligodendrocytes in culture exhibit very stereotyped patterns of cell division and differentiation, initially thought to reflect cell intrinsic regulation of the timing of their cell fate transitions (Durand and Raff 2000) . In vivo, however, life is more complex: Oligodendrocytes are specified in distinct germinal zones, from which they migrate as proliferative OPCs that ultimately colonize the gray and white matter of the entire CNS, where they either remain as OPCs or differentiate into oligodendrocytes (Fig. 1) . Despite their complex migration and colonization of the CNS, previous studies in which axons of the rodent optic nerve were transected showed that many aspects of OPC development through to their differentiation can occur in vivo in the absence of axons (Ueda and others 1999) . More recently, the development of OPCs and oligodendrocytes has been studied in zebrafish in the near absence of the specific axons that are targeted for myelination (Almeida and Lyons 2016) . Despite a 75% reduction in the number of target axons, the specification and migration of OPCs was unaltered, and the differentiation of OPCs into oligodendrocytes proceeded at a remarkably normal rate. These data further support the premise that many aspects of oligodendrocyte development can occur independently of axons (Almeida and Lyons 2016) . Indeed, numerous studies have identified the molecular mechanisms driving distinct stages of oligodendrocyte development, including transcription factors that autonomously regulate key stages of differentiation (reviewed by Emery and Lu 2015) . Furthermore, recent studies have shown how epigenetic regulators (reviewed by Liu and others 2016b), microRNAs (reviewed by Galloway and Moore 2016) and intracellular signaling pathways (reviewed by Gaesser and Fyffe-Maricich 2016) regulate oligodendrocyte lineage progression. Oligodendrocytes can not only differentiate in culture, but mature sufficiently to extend elaborate processes and synthesize sheets of myelin-like membrane, whether they are in contact with neurons or not (Simons and others 2000) . This indicates that oligodendrocytes have a default capacity to differentiate and initiate a program of myelin gene expression in the absence of axons. However, one might assume that the generation of an actual myelin sheath requires the axonal substrate around which it is formed, but recent studies suggest that this is not necessarily so.
Oligodendrocytes Do Not Require Living Axons to Make Myelin Sheaths!
Despite the intimate relationship between axons and their myelin sheaths in vivo, it now appears that the generation of myelin sheaths by oligodendrocytes does not actually require living axons. Oligodendrocytes in culture can myelinate paraformaldehyde-fixed axons (Rosenberg and others 2008) , and new models have been established to study myelination, using electron-spun polystyrene and poly-l-lactic acid fibers as inert axon-like substrates (Bechler and others 2015; S. Redmond and others 2016) . Indeed, inert structures have been developed that allow neuron-free high-throughput screening for regulators of myelination . The sheath-like structures formed around inert axon-shaped fibers are composed of several layers of membrane, and electron microscopic analyses indicate a higher order structure that resembles that of compact myelin sheaths (S. Bechler and others 2015) . Intriguingly, only inert fibers with a diameter of 0.4 µm and more are myelinated in vitro (S. , which is in keeping with in vivo observations that myelination is largely restricted to axons of this diameter and more (e.g., Remahl and Hildebrand 1982) . Furthermore, it has recently been shown that myelin sheath length may also be regulated by axon diameter in and of itself. In a remarkable observation made when studying myelination along inert axon-like fibers, Bechler and others (2015) found that oligodendrocytes cultured on fibers of mixed diameters from 0.5 to 4 µm generated longer myelin sheaths around larger caliber fibers. The fact that axons of larger caliber have more myelin was first observed over a century ago (Donaldson and Hoke 1905) and "The close relationship existing between diameter of the axon and whether or not it shall possess a myelin sheath" noted soon after (Duncan 1934) . However, the mechanisms by which axons of different diameter regulate myelination remain to be fully elucidated. Indeed, we now need to ask how the myelinating process of an oligodendrocyte can distinguish small from large caliber purely on a mechanical basis. Cell-cell contacts are usually mediated by adhesion complexes and there is indeed evidence of tight adhesion complexes between axons and oligodendrocytes at paranodes (see review by Zollinger and others 2015) , so how can the oligodendrocyte process wrap myelin membrane around an inert fiber substrate that does not provide any such specific molecular adhesion? A recent updated model of how the myelin sheath is wrapped around the axon may help to explain this paradox.
By analyzing the wrapping behavior of myelin sheaths using multiple imaging modalities, a new model has been proposed to explain how the multilamellar myelin sheath is formed. The sheath grows at the tip of the myelinating process (the leading edge), which moves around the axon. When the myelinating process has made one full wrap around the axon it meets itself and grows underneath the previous wrap. In so doing, continued growth of the myelinating process's leading edge serves to displace the overlying wrap along the axon. Consecutive iterations of this movement both increase wrap number and drive elongation of the sheath along the axon ( Fig. 2 ; Snaidero and others 2014) Follow-up biophysical and genetic analyses indicated that actin polymerization and depolymerization at the leading edge of the myelinating process drives this wrapping behavior (Nawaz and others 2015; Zuchero and others 2015) . Actin polymerization at the leading edge first leads to the formation of non-adhesive protrusions. Then actin depolymerization reduces the surface tension of these protrusions, which drives spreading and wrapping of membrane around the axon. Iterative rounds of this actin polymerization and depolymerization lead to the formation of the multilamellar sheath ( Fig. 2 ; Nawaz and others 2015) . During this process, adhesion of the myelin sheath is provided by interactions between overlying layers of myelin membrane. This means that a myelin sheath can, in principle, grow around an inert fiber with no requirement for adhesion between the leading edge and its target substrate. These observations suggest oligodendrocyte processes may be capable of simply recognizing the physical size of axonal targets, and myelinating them accordingly.
What molecular mechanisms might an oligodendrocyte process employ to respond to differences in axon diameter? Axons of different diameter have different degrees of curvature over the same physical distance, whereby smaller diameter axons have greater curvature, and larger axons less. This may have the consequence that the myelinating process has to bend to a greater extend to ensheath smaller diameter axons. Therefore, myelination may become increasingly difficult around axons of smaller diameter and potentially impossible around axons below the apparent threshold caliber for myelination. Interestingly, loss of function of the nonreceptor tyrosine kinases FAK (focal adhesion kinase) or Fyn cause severe hypomyelination of small-caliber axons in vivo, but have little effect on larger axons (Camara and others 2009; Umemori and others 1994) . FAK and Fyn have been shown to affect oligodendrocyte behavior by regulating both the actin and microtubule-based cytoskeleton (Krämer-Albers and White 2011; Lafrenaye and Fuss 2010) , suggesting that the myelination of smaller diameter fibers might require enhanced cytoskeletal flexibility compared to myelination of larger diameter targets. The molecular basis by which oligodendrocytes might recognize differences in curvature are not clear. However, curvature-sensing molecules, for example, BAR proteins, are known to exist, and play active roles in both curvature sensing and the induction of curvature of the cell membrane itself (reviewed by Antonny 2011) . Although no such molecules have yet been found to regulate myelination, the BAR protein Bin1 has recently been found to be up-regulated in oligodendrocytes (De Rossi and others 2016) . Bin 1 is expressed at the onset of postnatal myelination in the brain, and during differentiation of cultured oligodendrocytes, which suggest a potential role in myelin wrapping. The relationship between curvature sensing/inducing molecules and the cytoskeleton during myelination may be an important area of future investigation.
The work we have described thus far suggests that the default ability of oligodendrocytes to differentiate and to myelinate axons of different diameter may play a large role in generating the diversity of myelination observed in vivo. Indeed, axons in the CNS differ in diameter by nearly 100-fold (~0.1-10 µm) (Perge and others 2012) , and therefore in the perimeter cell surface accessible to oligodendrocyte processes by more than 300-fold. Thus, variation in axonal caliber alone represents a large dynamic range to which the myelinating process could (A) The myelinating process (green) grows and wraps around and along an axon/axon-like fiber (pink), with the leading edge tip (light green) growing underneath the previous later, and displacing it along the axon in so doing. (B) Growth of the myelinating process during sheath formation, seen as if flattened out. Growth occurs through iterative phases of actin polymerization (F-actin, lines) at the leading edge (light green) and actin depolymerization (G-actin, dots). First, the leading edge pushes forward then subsequently flattens, resulting in spreading of the membrane sheath. (C) Growth of the myelinating process as seen in cross section, with presumptive location of actin indicated at stages that correspond to images in A and B. Boxes i and ii highlight that adhesion between wraps of myelin membrane may ensure sheath integrity without the need for adhesion to the axon/fiber substrate. (D) Electron micrograph of myelinated axons before final compaction. The space between first sheath around the axon and consecutive myelin membrane layers is still visible (box). Image provided by Dr. Mikael Simons. respond to tune myelin sheath growth. Therefore, to fully understand how CNS myelination is fundamentally regulated in vivo, it will be important to determine how and why different axons grow to different calibers, something that is currently poorly understood.
Axon Caliber and Molecular Signals Are Correlated
In the peripheral nervous system (PNS) myelination is carried out by neural crest-derived Schwann cells, and in the PNS essentially all axons above a diameter of 1 µm are myelinated, with almost all below remaining unmyelinated (Duncan 1934) . In a seminal study, James T Voyvodic showed that when small unmyelinated axons of the PNS are stimulated to grow in caliber, this leads to their myelination (Voyvodic 1989) . This indicates that either caliber itself and/or signals that correlate with caliber can stimulate myelination by Schwann cells. It is now thought that the growth factor Neuregulin 1 is the proxy readout of axon caliber in the PNS that drives myelination (see review by Birchmeier and Nave 2008) . Larger caliber axons express more Neuregulin1 than smaller axons (Taveggia and others 2005) , and overexpression of Neuregulin1 can induce myelination of non-myelinated peripheral axons (Taveggia and others 2005) and the generation of thicker myelin sheaths on myelinated axons (Michailov and others 2004) . Genetic knockout of Neuregulin1 or its cognate Erbb2/3 receptors from Schwann cells results in a complete lack of peripheral nerve myelination (Birchmeier and Nave 2008) . Thus, in the PNS, Neuregulin1 represents the primary signal by which large-caliber axons drive myelination by Schwann cells. Interestingly, the role for axonal signals may be more important for myelination by Schwann cells than oligodendrocytes, given that Neuregulin-ErbB signaling seems to be largely dispensable for CNS myelination (Brinkmann and others 2008) and that Schwann cells appear unable to myelinate inert fibers by default (Bechler and others 2015) .
The role that axon caliber plays in the CNS has also been investigated, as Waxman and Sims noted more than 30 years ago that an individual oligodendrocyte produces more myelin wraps around larger caliber axons, thus the individual myelinating process distinguishes between axon diameters (Waxman and Sims, 1984) . More recently, the role that axon caliber plays in the CNS functionally in vivo has also been investigated. In one study, Almeida and others (2011) introduced supernumerary neurons with very large caliber axons into the zebrafish CNS. Because OPCs exhibit a relatively limited degree of proliferation in the larval zebrafish spinal cord, the authors were able to assess how the presence of additional large caliber axons affected oligodendrocyte differentiation, and myelination. In line with the observations that oligodendrocyte differentiation does not require specific target axons (Almeida and Lyons 2016) , the overall number of myelinating oligodendrocytes did not change in the presence of extra-large caliber targets, but myelination was strikingly affected (Almeida and others 2011) . In wildtype animals, individual oligodendrocytes typically myelinate either a large number of relatively small caliber axons or a small number of very large caliber axons (Almeida and others 2011), as first observed by Pio Del Rio-Hortega almost a century ago. However, in the presence of additional very large caliber axons, individual oligodendrocyte generated more myelin sheaths per cell and also readily myelinated both very large and relatively small axons (Almeida and others 2011) . However, in this study, the relative contribution of axon caliber and the signals that correlate with caliber, were not disentangled.
A more recent study has begun to address the relative contribution of caliber and associated signals in regulating CNS myelination by oligodendrocytes in vivo. Goebbels and others (2017) used a genetic targeting approach in mice to inactive PTEN (phosphatase and tensin homolog) selectively in granule cells (GCs) of the cerebellum, which normally have very small caliber unmyelinated axons. This manipulation stimulated the Akt-mTor growth pathway and led to a significant increase in the caliber of GC axons, and in turn to their robust myelination. Knockout of PTEN from almost all GCs first led to the increased proliferation and subsequent differentiation of OPCs in their vicinity. Interestingly, inactivation of PTEN in only a small number of GCs also led to a striking increase in OPC proliferation and differentiation. This suggests that it may be the signals that are induced, and likely secreted, on PTEN inactivation, which stimulate the early stages of oligodendrocyte development, rather than the growth of axons in caliber per se. At later stages, however, evidence of a direct relationship between caliber and actual myelination was observed in PTEN-deficient GC axons, whereby only axons that had grown in caliber to >250 nm became myelinated (Goebbels and others 2017) . The authors went further to identify candidate signals expressed by GCs with large caliber axons that may mediate distinct stages of oligodendrocyte development and myelination. They found that the neurotrophin BDNF (brain-derived neurotrophic factor) (and several other factors) was upregulated in the cerebellar granule layer of PTEN conditional knock out (cKO) animals. Interestingly, the increase in OPC proliferation and differentiation observed in PTEN cKO mutants was further increased on BDNF loss from GCs, whereas the myelination promoted by PTEN cKO was slightly reduced on BDNF loss (Goebbels and others 2017) . These data indicate that BDNF may differentially regulate early and later stages of oligodendrocyte development, and may be a factor that correlates and cooperates with axonal caliber in regulating CNS myelination. Further investigation of additional factors whose expression correlates with growth of axon caliber will be required to fully disentangle how caliber per se and the signals that correlate with caliber regulate myelination.
Neuronal Signals and Myelination
In vivo, axons are almost exclusively the targets for myelination and other neuronal subdomains like dendrites and cell bodies are not myelinated. This is the case even in neurons like Purkinje cells, which have myelinated axons and unmyelinated dendrites of much larger caliber. This implies that axons may have signals (beyond caliber) that bias myelination toward them, or that cell bodies and dendrites may have signals that bias myelination away from them. The specific selection of axons for myelination is also observed in neuron-oligodendrocyte co-cultures, but if oligodendrocytes are cultured on neurons that are pre-fixed with paraformaldehyde, then their cell bodies and dendrites can indeed become myelinated . This indicates that there must be specific signals controlling axonal-specific myelination. The neuronal junction adhesion molecule JAM2 has recently been identified as a signal that inhibits myelination of neuronal cell bodies and dendrites (the somato-dendritic compartment) . In this study, the authors first performed a differential RNA-seq based screen to identify cell surface molecules enriched in dendrites (by comparing gene expression between spinal cord neurons with extensive dendrites and DRG neurons that lack dendrites). From these analyses, JAM2 was found to be localized to neuronal cell bodies and dendrites, and therefore considered as a candidate negative regulator of myelination of the somato-dendritic compartment. Indeed, it was found that myelination of dendrites of Jam2 deficient neurons was increased by more than 300% in co-cultures with wildtype oligodendrocytes . Furthermore, in vivo analyses of JAM2 knock out mice revealed a 5-fold increase in myelination of neuronal cell bodies in the dorsal horn of the spinal cord. Thus, Jam2 directly prevents the myelination of neuronal cell bodies and dendrites. Given that Jam2, and possibly additional factors, can regulate the targeting of myelin to axons, and that caliber may determine which axons are myelinated and how myelin sheaths grow, could these factors together with the ability of oligodendrocytes to differentiate by default, be sufficient to regulate CNS myelination? Recent documentation of the diversity of CNS myelination in vivo suggests otherwise.
Diversity in CNS Myelination
Myelination in the CNS is now known to occur throughout life, and different brain areas become myelinated for the first time in humans years apart (Yeung and others 2014) . Furthermore, recent studies have indicated striking diversity in myelination of axons of different neuronal subtypes. For example, detailed analysis of large 3-dimensional electron microscope datasets revealed diversity in myelination along the axons of cortical pyramidal (Tomassy and others 2014) . Neurons in deeper cortical layers exhibited relatively uniform characteristic myelination along their axons. In contrast, the axons of superficial cortical layer neurons were found to be less myelinated, whereby consecutive myelin sheaths are often interspersed by very long unmyelinated stretches (Tomassy and others 2014) . Another recent study has revealed further diversity in cortical myelination. Previously it was thought that cortical myelination was predominantly restricted to long-range excitatory projection axons. However, using array tomography and additional analyses of 3-dimensional electron microscope datasets, Micheva and others (2016) found that a large proportion of cortical myelin is generated along the axons of short-range GABA-ergic inhibitory neurons. Interestingly, the pattern of myelination along individual GABA-ergic axons was also that of a patchy distribution of short myelin sheaths interspersed by large unmyelinated gaps. This study also showed that the myelin sheaths made along GABA-ergic axons were distinctly smaller than those of neighboring axons of excitatory neurons. These data suggest that differences in neurotransmitter expression may play a role in regulating the specific pattern of myelination along axons, as we will discuss below.
Additional studies have indicated that the specific pattern of myelination along axons can be exquisitely regulated to mediate very precise conduction times (reviewed in Seidl 2014). One well-described example wherein conduction times affect function, is in the integration of auditory input from both ears (Seidl 2014) . Auditory information in the avian brainstem is received by neurons of the nucleus magnocellularis (NM), which extend axons that bifurcate, with one branch projecting to the ipsilateral nucleus laminaris and a much longer branch to equivalent neurons on the contralateral side. These NM axon branches thus innervate corresponding bilateral coincidence detector neurons that receive information from both ears. To process the location of auditory information accurately, impulses at the bilateral coincidence detector neurons needs to arrive simultaneously following propagation along the short and the long axon branches of the NM neurons (Seidl and others 2010) . Anatomical analyses indicated that this is achieved by both rerouting of the short axon on a slightly longer circuitous route, but also by increasing both axon diameter, and myelin sheath length and thickness along the longer branch. These differences predict that signal propagation in the longer branches is twice as fast as along the shorter branch, and that as a consequence conduction times are similar along both (Seidl and others 2010) . Regulation of myelination along axons in accordance with specific conduction requirements has also been observed in mammals (e.g., Lang and Rosenbluth 2003; Salami and others 2003; Sugihara and others 1993) . As noted previously, larger caliber axons are typically associated with longer myelin sheaths. However, in a recent study of the auditory processing circuit of the gerbil, Ford and others (2015) found a disconnect in this relationship. They found that the axons of neurons that responded to low-frequency sounds were of larger caliber than those responding to high frequencies, reflecting the need for more rapid conduction along their length due to the spatial organization of the tonotopic map in the target area (Ford and others 2015) . Surprisingly though, these larger caliber axons also had somewhat shorter myelin sheaths than neighboring smaller caliber axons responsive to high frequencies, which one may have thought would result in slower conduction. However, computer simulations integrating multiple anatomical and biophysical properties predicted that the observed combination of axon caliber and myelin sheath length in the low-frequency responding axons should actually provide the fastest conduction, a prediction validated by in vivo recordings (Ford and others 2015) . This result beautifully illustrates the capacity of the nervous system to apparently fine-tune myelination to sub-serve specific functional needs. Indeed, an everincreasing body of evidence now clearly indicates that neuronal activity does indeed act as a significant regulator of CNS myelination in vivo.
Role of Neuronal Activity in Regulating Myelination
Numerous studies, dating back more than 50 years, have investigated how neuronal activity regulates many aspects of oligodendrocyte development and myelination both in vitro and in vivo, and this topic has been extensively reviewed recently (e.g., Baraban and others 2016; Chang and others 2016; Fields 2015) . Therefore, we will focus here on recent studies that have investigated how activity-related axonal signals regulate oligodendrocyte development and myelination in vivo.
A recent study used optogenetic technology to activate neurons in the living mouse motor, and found that a specific activation paradigm lead to a remarkable proliferative response of OPCs, and a subsequent increase in oligodendrocyte differentiation and myelination (Gibson and others 2014) . In a follow-up study focusing on the proliferative response of OPCs, Venkatesh and others (2015) found that the same optogenetic stimulation paradigm led to the secretion of the synaptic organizer protein Neuroligin 3, which was found to be a powerful OPC mitogen. It remains to be determined, whether the optogenetic stimulation of neuronal activity independently regulates OPC proliferation, differentiation and myelination, or whether the observed effects on differentiation and myelination occur by default following the increase in proliferation.
In addition, several new studies using zebrafish as a model have addressed the role of neuronal activity in regulating the myelinating behavior of oligodendrocytes. In vivo time-lapse imaging studies indicate that on differentiation, individual oligodendrocytes undergo a period of dynamic process extension and retraction. During this time the cell's processes make contact with numerous axons, on which they form many nascent myelin sheaths (Czopka and others 2013; Hines and others 2015) . Over a short period of about 5 hours, individual nascent myelin sheaths are either fully retracted or stabilized, leading to the formation of mature myelin sheaths (Czopka and others 2013) . In two parallel studies, Hines et al. and Mensch et al. found that disruption of tetanus toxin-sensitive vesicular release from all neurons leads to individual oligodendrocytes generating fewer myelin sheaths per cell (Hines and others 2015; Mensch and others 2015) . Time-lapse analyses indicated that this reduction in myelin sheath number resulted from the stabilization of fewer myelin sheaths during the short period of nascent sheath retraction and stabilization (Hines and others 2015) . Conversely, increasing neuronal activity resulted in more myelin sheaths being formed by individual cells, in a vesicular-release regulated manner (Mensch and others 2015) . These data suggest that vesicular release regulates the behavior of individual myelinating processes. Additional analyses provide direct evidence that this is mediated by localized signaling between the axon and the myelinating processes. Instead of blocking vesicular release from all axons, vesicular release was prevented only from single axons in an otherwise normal environment, which resulted in fewer myelin sheaths being formed along axons with impaired vesicular release (Hines and others 2015; Koudelka and others 2016; Mensch and others 2015) . Interestingly, the selection of active over inactive axons for myelination has also been observed in axon-oligodendrocyte co-cultures of mammalian cells, where fewer myelin sheaths are formed along axons with disrupted vesicular release compared to neighboring control axons (Wake and others 2015) . In both the zebrafish and mammalian studies, it was observed that the myelin sheaths that did form on axons with reduced vesicular release, were significantly shorter than those made on control axons (Hines and others 2015; Koudelka and others 2016; Wake and others 2015) . This suggests, that vesicular release may play, at least, two independent roles in the local regulation of myelination, first in myelin sheath formation, and second in their subsequent growth.
In order to determine whether all or only some specific axons regulate myelination in a vesicular release dependent manner, Koudelka et al., inhibited vesicular release from distinct neuronal subtypes in the living zebrafish. Whereas blocking vesicular release from one neuronal subtype (reticulospinal neurons) led to a striking decrease in the number and length of myelin sheaths made along their axons, blocking vesicular release from a second neuronal subtype (commissural primary ascending, CoPA, neurons) had no effect on myelination (Koudelka and others 2016) . Interestingly, reticulospinal and CoPA axons are of the same caliber, suggesting that distinct signaling mechanisms must regulate their myelination, one through vesicular release, and the other possibly either by the default caliber-driven mechanism or via alternative signaling pathways.
The observation that vesicular release can regulate myelination raises the simple question as to what specific vesicular cargo(es) regulate myelination. In the zebrafish and mammalian studies, the neurotoxins tetanus and botulinum, respectively, were used to prevent vesicular release. These toxins cleave vesicular SNARE proteins, most prominently VAMP2, essential for vesicle fusion with the cell membrane (Südhof 2013) , and thus prevent the release of cargo into the extracellular space, for example, at the synapse or the interface between the axon and the myelinating process of the oligodendrocyte. The primary vesicles targeted by these toxins are synaptic vesicles, and thus neurotransmitters are prime candidates to mediate effects on myelination. Indeed, localized release of the principle CNS neurotransmitter glutamate release has previously been implicated in regulating myelination by oligodendrocytes in vitro (e.g., Wake and others 2011). However, these toxins do also prevent the vesicular release of other vesicles and candidate molecules, for example, the neurotrophin BDNF (Shimojo and others 2015) , which, as noted earlier has previously been implicated in myelination. It is also possible, that distinct factors affect different aspects of myelination, for example, initial formation/stabilization and subsequent growth/ remodeling.
Recently, the specific role of glutamate release in regulating myelination has been tested in vivo. By conditionally knocking out the vesicular glutamate transporter vglut2 in retinal ganglion cells of mice, Etxeberria and others (2016) aimed to investigate how glutamate release affects myelination along the optic nerve. Interestingly, they observed that the myelin sheaths made by oligodendrocytes along retinal ganglion cell axons with impaired glutamate release were significantly shorter than in controls (Etxeberria and others 2016) , mirroring the effect of vesicular release blockade on sheath length (Hines and others 2015; Koudelka and others 2016) . However, they also found that attenuating vesicular release of glutamate from retinal ganglion cells resulted in increased numbers of oligodendrocytes, suggesting that glutamate may negatively regulate oligodendrocyte differentiation (Etxeberria and others 2016) . This result contrasts with observations that reduction in vesicular release lead to a small decrease in oligodendrocyte number in the zebrafish spinal cord (Mensch and others 2015) . This difference may reflect region-specific differences in axon-oligodendrocyte interactions, as has been suggested by recent RNA-seq profiling studies indicating diversity in the oligodendrocyte lineage (Marques and others 2016) . Alternatively, this apparent contradiction may simply reflect the existence of additional factors disrupted following vesicular release blockade, compared with the reduction of glutamate release alone.
In another recent study of the effect of neurotransmitters on oligodendrocyte development and myelination, Hamilton and others (2017) found that stimulating GABA release in an ex vivo slice model reduced oligodendrocyte number, whereas blocking GABA receptor function increased cell number. Interestingly, they also found that myelin sheath length was reduced following GABA release. It will be important to disentangle the effects of glutamate and GABA release on oligodendrocyte differentiation, and myelination, because it is known that the density of oligodendrocytes can directly affect myelination Rosenberg and others 2008) , whereby higher densities of oligodendrocytes lead to individual cells generating less myelin, and lower densities more myelin per cell.
In line with their putative role regulating oligodendrocyte behavior, there is extensive evidence that oligodendrocyte lineage cells express receptors for and respond to glutamate and GABA. Indeed, OPCs even form bona fide synapses with glutamatergic (Bergles and others 2000; Kukley and others 2007; Ziskin and others 2007) and GABA-ergic axons (Lin and Bergles 2003) , although this synaptic communication diminishes with differentiation and myelination (De Biase and others 2010). However, mature myelin sheaths do retain expression of neurotransmitter receptors (e.g., Micu and others 2016). The role of neurotransmitter receptors in the oligodendrocyte lineage has been extensively reviewed elsewhere (e.g., Maldonado and Angulo 2015) , and remains under intensive investigation.
Localized Switching from Default Myelination to Activity-Regulated Myelination?
The finding that not all neurons regulate myelination along their axons in a vesicular release-regulated manner (Koudelka and others 2016) has implications for neuronal circuit function. Some axons may simply require default myelination to maximize conduction velocity along large axons, whereas others may need more precisely regulated myelination to ensure specific conduction times for circuit function and neuronal communication. Interestingly, a recent study has suggested that axonal signals may regulate a transition between distinct modes of myelination.
Studying myelination in co-cultures, Lundgaard and others (2013) found that exogenous application of Neuregulin enhanced CNS myelination, and also made myelination much more sensitive to manipulation by neuronal activity. Whereas treatment of control co-cultures with the sodium channel blocker TTX or antagonists of glutamateric NMDA receptors had little effect on myelination, co-treatment with Neuregulin resulted in severely impaired myelination (Lundgaard and others 2013) . The authors propose that axonal Neuregulin regulates NMDAR expression and function in oligodendrocytes, via interactions with ErbB receptors, as can occur at neuronal synapses (Mei and Nave 2014) . The prediction is that this change in oligodendrocyte NMDAR localization and function makes the myelinating processes more sensitive to the effects of neuronal activity and neurotransmitter.
Here we propose a model that aims to unify these observations with the recent in vivo studies of vesicular release-regulated myelination by oligodendrocytes. Previous studies have shown that specific forms of neuronal activity can regulate Neuregulin (Liu and others 2011) . Therefore, it is possible that different neurons with distinct firing patters will have different levels or indeed isoforms of Neuregulin (Neuregulin 1 has numerous splice variant isoforms (Birchmeier and Nave 2008)) . Certain axons may then be able to locally regulate neurotransmitter receptor expression/localization in associated myelinating processes, and make their associated myelinating process more or less responsive to neurotransmitter release. In the absence of vesicular release from axons with high levels or specific isoforms of Neuregulin, myelination along that axon might be profoundly affected due to the increased sensitivity of associated myelinating processes to regulation by neurotransmitter release. In axons with less or alternative isoforms of Neuregulin, it is possible that no localized regulation of neurotransmitter receptors will occur in myelinating processes and thus the myelination of those axons would be impervious to disruption to vesicular release (Fig. 3) . This hypothesis needs investigation in vivo, and it also remains to be determined whether the myelination of axons unresponsive to neurotransmitters release would revert to a default, caliberdriven mode of myelination, or whether additional signals, which remain to be identified regulate the myelination of such axons. One prediction of this model is that abrogation of Neuregulin function would eliminate activity-regulated myelination, and potentially leave in place default a caliber-driven myelination, which has interesting implications for how disruption to Neuregulin-Erbb signaling might affect circuit function. Indeed, it is noteworthy that although Neuregulin and Erbb receptors are dispensable for CNS myelination per se (Brinkmann and others 2008) , loss of Erbb3 signaling from oligodendrocytes leads to reduced complexity of myelinating oligodendrocyte morphology and to behavioral defects that phenocopy postnatal myelination (Makinodan and others 2012) . It is also interesting to note that disruption of Neuregulin and CNS myelination have also been observed in conditions like schizophrenia (Takahashi and others 2011) , in which dysregulation of the precise timing of information transmission is observed. However, it is, of course, entirely possible that a range of additional axonal signals regulate and fine tune distinct aspects of myelination, independently of vesicular release, caliber, and Neuregulin.
Who Says "Go"?
As noted throughout this piece, oligodendrocytes have a capacity for default differentiation, but the location and timing of differentiation and myelination is highly regulated in vivo, which begs the question as to what tells oligodendrocytes that it is time to differentiate and initiate a program of gene expression for myelination. One extreme view is that "GO" occurs simply according to an intrinsic clock set as part of the default differentiation program. However, this view is incompatible with numerous in vivo studies. For example, live imaging studies of the developing zebrafish spinal cord (Kirby and others 2006) and the adult mouse cortex (Hughes and others 2013) show that OPCs are highly dynamic and interactive cells, constantly extending dynamic processes that survey the local environment. Indeed, interactions between OPCs are important for homeostatic maintenance of the cell population (Hughes and others 2013; Kirby and others 2006) . It is possible that such interactions may even regulate the timing of differentiation, whereby the "GO" signal is triggered by interactions between the processes of neighboring OPCs, once they have reached a specific distribution and density.
Additionally, or alternatively, interactions of the exploratory processes of OPCs with axons may trigger a "GO" signal. The "GO" signal may be secreted from target axons or require direct cell-cell contact between axons and oligodendrocyte processes (Fig. 4) . Indeed, inhibitory axonal signals have already been identified that regulate the timing of oligodendrocyte differentiation and myelination. The first inhibitory molecule observed to regulate myelination in the CNS was PSA-NCAM (polysialic acid-neuron cell adhesion molecule): PSA-NCAM is initially expressed by all axons, but its downregulation coincides with myelination, whereby only PSA-NCAM negative axons become myelinated. Premature removal of PSA-NCAM leads to premature myelination in vitro, although its role in vivo remains to be confirmed (reviewed by Mei and others 2013) . In addition, the cell adhesion molecule Lingo-1 has also been implicated as a negative regulator of myelination. Axonal overexpression of Lingo-1 inhibits myelination, and abrogation of Lingo-1 accelerates oligodendrocyte differentiation and myelination, not only in the healthy nervous system but also during myelin regeneration (reviewed by Mei and others 2013). Indeed, antibodybased inhibition of Lingo-1 has undergone a clinical trial with the aim of enhancing myelin regeneration in multiple sclerosis. The presence of additional inhibitory signals regulating the timing of oligodendrocyte differentiation, and myelination, is implied by analyses of oligodendrocyte-specific knockout of G-protein coupled receptors (GPCR). A number of GPCRs are known to be expressed by oligodendrocytes and to regulate their timely differentiation and myelination (reviewed in Mogha and others 2016) . Oligodendrocyte-specific deletion of GPR17 and GPR37 in the CNS results in precocious differentiation and myelination (Mogha and others 2016) . To date, no axonal ligands for these GPCRs have been identified that affect CNS myelination. Although axons may be the source of such ligands, it is important to point out that other cell types, or even the surrounding extracellular matrix (ECM) also may act as ligand sources. In the PNS for example, the ECM components laminin-211 and collagen IV are ligands for GPCR126, which is required by Schwann cells for PNS myelination (Mogha and others 2016) . As we noted with respect to the roles that glutamate and GABA may play in oligodendrocyte differentiation and CNS myelination, it will be important to determine whether and how different inhibitory molecules specifically regulate the timing of oligodendrocyte differentiation and/ or myelination.
In addition to the removal of inhibitory signals that allow oligodendrocytes to "GO" and differentiate, there may also be positive extrinsic factors regulating the timing of this transition. However, it is entirely possible that inhibitory signals combined with the default ability of oligodendrocytes to differentiate provides sufficient regulation of the timing of myelination in vivo. 
Summary and Future Perspectives
In summary, it is now clear that oligodendrocytes have a default ability to differentiate. However, the timing of differentiation in vivo needs to be tightly controlled and this may be mediated by interactions between oligodendrocytes and/ or extrinsic inhibitory signals. Following differentiation, oligodendrocytes extend and retract multiple processes in order to select specific axons for myelination, which is likely to be mediated by at least two mechanisms. On one hand, the myelinating processes of oligodendrocytes are responsive to the simple biophysical property of axon caliber alone (Bechler and others 2015) , and thus it remains possible that the diversity of axon caliber observed in vivo plays a major role in axonal selection for myelination in the CNS. On the other hand, it is also clear that extrinsic signals can at the very least fine tune axonal selection for myelination, as indicated by the fact that oligodendrocytes avoid inappropriate targets such as neuronal cell bodies and dendrites, and have a preference for generating myelin sheaths on more active axons (Koudelka and others 2016; Wake and others 2015) . Following the initial formation of myelin sheaths, individual sheaths grow along and around the axon (Snaidero and others 2014) , often to very specific lengths and thicknesses that confer precise conduction properties to the axon (e.g., Ford and others 2015) . Although it appears that the biophysical property of axon caliber alone can also influence the size of individual myelin sheaths (Bechler and others 2015) , the diversity of myelination on specific axons in vivo strongly indicates that specific signals are required to fine tune myelin sheath size, and consequently, circuit function. Indeed, in recent years it has become clear that dynamic lifelong regulation of myelination is likely to refine neuronal circuit function (Fields 2015) . Therefore, it will be essential for future studies to investigate the mechanisms by which myelin sheaths are regulated along axons over time, in distinct neuronal circuits, and in response to diverse changes in the environment. Indeed it is now also clear that dynamic regulation of other aspects of myelinated axon structure, such as the shape and size of nodes of Ranvier, may profoundly regulate circuit function (Ford and others 2015) . Furthermore, various other components of the CNS-astrocytes (Ishibashi and others 2006) , microglia (Miron and others 2013) , vasculature (Yuen and others 2014)-can influence oligodendrocyte development and myelination. Indeed, even the non-cellular ECM can influence differentiation, not only through activating typical signaling pathways but also due to regulation of physical properties such as stiffness (Lourenço and Grãos 2016) .
Therefore, future studies will need to take a holistic view of the myriad of cellular and molecular interactions that regulate myelination in the CNS. Such understanding will provide fundamental insight into mechanisms that regulate CNS formation, function, and lifelong health.
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